Evidence map›Paper›PMID 40777575›Full record

ArticleBrain disorders (Amsterdam, Netherlands)2023

A narrative review to guide treatment and care for children with Tourette syndrome.

Christopher Manbeck, Tara Johnson, Gregory Sharp

Abstract read
In one paragraph

Article in Brain disorders (Amsterdam, Netherlands), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Christopher ManbeckArkansas Children's Hospital and University of Arkansas Medical Sciences, United States.
Tara JohnsonArkansas Children's Hospital and University of Arkansas Medical Sciences, United States.
Gregory SharpArkansas Children's Hospital and University of Arkansas Medical Sciences, United States.

Funding

Expanding Translational Research in ArkansasUL1TR003107 · NCATS · UNIV OF ARKANSAS FOR MED SCIS · PI JAMES, LAURA P · 2019 to 2023
$21.6M
NCATS NIH HHS UL1 TR003107
6 · The paper itself

Abstract

Tourette syndrome is a spectrum disorder. It is primarily a disorder of childhood. Within this spectrum, we find a range of neuropsychiatric comorbidities of varying degrees, all of which are intertwined. Before we consider treatment, we must address education, which includes the individual, the family, the school, and the public. Our approach to treatment focuses on the dominant comorbidities: ADHD, mood disorders, anger/aggression, refractory tics, and finally tics only. We select medications and therapies designed to target the driving issues.

Indexed as

ADHDAnxietyCBITDepressionMood disordersOCDRefractor ticsTic disorderTourette disorderTourette syndrome

Identifiers

PMID40777575
PMCPMC12330826

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.